Regulation of p27(Kip1) accumulation in murine B-lymphoma cells: Role of c-Myc and calcium

Cell Growth and Differentiation

Volumn 10, Issue 10, 1999, Pages 695-704

  Donjerković, Dubravka ^a,b   Zhang, Liying ^a   Scott, David W ^a,b  

^a HOLLAND LABORATORY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD40 ANTIGEN; IMMUNOGLOBULIN M; MEVINOLIN; PROTEIN P27; TRANSCRIPTION FACTOR; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CD40 LIGAND; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOSPORIN; ENZYME INHIBITOR; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MYC PROTEIN; PEPTIDE CHLOROMETHYL KETONE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHELATION; CROSS LINKING; DOWN REGULATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN EXPERIMENT; LYMPHOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; ANIMAL; B CELL LYMPHOMA; CELL LINE; CYTOSOL; DRUG ANTAGONISM; METABOLISM; MOUSE; TUMOR SUPPRESSOR GENE;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CALCIUM; CASPASES; CD40 LIGAND; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLOSPORINE; CYTOSOL; DOWN-REGULATION; ENZYME INHIBITORS; G1 PHASE; GENES, TUMOR SUPPRESSOR; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEINS;

EID: 0032589803     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Scott, D. W., Livnat, D., Pennell, C. A., and Keng, P. Lymphoma models for B cell activation and tolerance III. Cell cycle dependence for negative signaling of WEHI-231 B lymphoma cells by anti-μ. J. Exp. Med., 164: 156-164, 1986.
2. Benhamou, L. E., Cazenave, P-A., and Sarthou, P. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol., 20: 1405-1407, 1990.
3. Hasbold, J., and Klaus, G. G. B. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol., 20: 1685-1690, 1990.
4. Joseph, L. F., Ezhevsky, S., and Scott, D. W. Lymphoma models for B cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell Growth Differ., 6: 51-57, 1995.
5. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 8: 323-330, 1995.
6. DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C-M., and Livingston, D. M. The product of the retinoblastoma susceptibility gene has a properties of a cell cycle regulatory element. Cell, 58: 1085-1095, 1989.
7. Buchkovich, K., Duffy, L A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
8. Mihara, K., Cao, X-R., Yen, A., Chandler, S., Driscolli, B., Murphree, A. L., T'Ang, A., and Fung, Y-K. T. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (Washington DC), 246: 1300-1303, 1989.
9. Roberts, J. M., Koff, A., Polyak, K., Firpo, E., Collins, S., Ohtsubo, M., and Massagué, J. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb. Symp. Quant. Biol., 59: 31-38, 1994.
10. Sherr, C. J., Kato, J., Quelle, D. E., Matsuoka, M., and Roussel, M. F. D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response. Cold Spring Harb. Symp. Quant. Biol., 59: 11-19, 1994.
11. Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., and Pagano, M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol., 15: 2612-2624, 1995.
12. Resnitzky, D., and Reed, S. I. Different roles for cyclins D1 and E in regulation of the G1-to S transition. Mol. Cell. Biol., 15:3463-3469, 1995.
13. Rosenberg, A. R., Zindy, F., Le Deist, F., Mouly, H., Metezeau, P., Brechot, C., and Lamas, E. Overexpression of human cyclin A advances entry into S phase. Oncogene, 10: 1501-1509, 1995.
14. Ezhevsky, S. A., Toyoshima, H., Hunter, T., and Scott, D. W. Role of cyclin A and p27 in anti-lgM-induced G1 growth arrest of murine B cell lymphomas. Mol. Biol. Cell, 7: 553-564, 1996.
15. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
16. Gu, Y., Rosenblatt, J., and Morgan, D. O. Cell cycle regulation of Cdk2 activity by phosphorylation of Thr160 and Tyr15. EMBO J., 11: 3995-4005, 1992.
17. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
18. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
19. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
20. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
21. Poon, R. Y. C., Toyoshima, H., and Hunter, T. Redistribution of the CDK inhibitor p27 between different cyclin:CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell, 6: 1197-1213, 1995.
22. Kip1. Mol. Cell. Biol., 15: 4347-4352, 1995.
23. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
24. Reynisdottir, I., Polyak, K., lavarone, A., and Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
25. Kip1 accumulation during the cell cycle. Science (Washington DC), 277: 1861-1864, 1996.
26. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
27. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., and Eilers, M. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 75: 2561-2576, 1997.
28. Kip1. EMBO J., 16: 5334-5344, 1997.
29. Kip1. Genes Dev., 11: 1464-1478, 1997.
30. Morisaki, H., Fujimoto, A., Ando, A., Nagata, Y., Ikeda, K., and Nakanishi, M. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Biochem. Biophys. Res. Commun., 240: 386-390, 1997.
31. Motagnoli, A., Fiore, F., Eytan, Esther, Carrano, A., Draetta, G. F., Hershko, A., and Pagano, M. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev., 13: 1181-1189, 1999.
32. Kip1 is instigated by Jab1. Nature (Lond.), 398: 160-165, 1999.
33. Kip1 binding to newly formed complexes. Oncogene, 14: 2373-2381, 1997.
34. Pusch, O., Bernaschek, G., Eilers, M., and Hengstschlager, M. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene, 15: 649-656, 1997.
35. Kip1 is abrogated by c-Myc. EMBO J., 15: 6595-6604, 1996.
36. Leone, G., DeGregori, J., Sears, R., Jakoi, L., and Nevins, J. R. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (Lond.), 387: 422-426, 1997.
37. Nass, S. J., and Dickson, R. B. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Clin. Cancer Res., 7: 1813-1822, 1998.
38. Mateyak, M. K., Obaya, A. J., and Sedivy, J. M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol., 19: 4672-4683, 1999.
39. Heckford, S. E., Gelman, E. P., Agnor, C. L., Jacobson, S., Zinn, S., and Matis, L. A. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones. J. Immunol., 137: 3652-3663, 1986.
40. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
41. Scott, D. W., Lamers, M., Kohler, G., Sidman, C. L., Maddox, B., and Carsetti, R. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells. Int. Immunol., 8: 1375-1385, 1996.
42. Solvason, N., Wu, W. W., Kabra, N., Wu, X., Lees, E., and Howard, M. C. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med., 184: 407-417, 1996.
43. Fischer, G., Kent, S. C., Joseph, L., Green, D. R., and Scott, D. W. Lymphoma models for B cell activation and tolerance X. Anti-μ-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by stabilization of myc. J. Exp. Med., 179: 221-228, 1994.
44. Scott, D. W., Donjerkovic, D., Maddox, B., Ezhevsky, S., and Grdina, T. Role of c-Myc and p27 in anti-IgM induced B-lymphoma apoptosis. Curr. Top. Microbiol. Immunol., 224: 103-112, 1997.
45. Scott, D. W., Brunner, T., Donjerkovic, D., Ezhevsky, S., Grdina, T., Green, D., Shi, Y., and Yao, X. R. Murder and suicide: a tale of T and B cell apoptosis. In: Y. B. Shi, Y. Shi, D. W. Scott, and X. Yu (eds.), Programmed Cell Death, pp. 91-103. New York: Plenum Publishing Corp., 1997.
46. Wu, M., Arsura, M., Bellas, R. E., FitzGerald, M. J., Lee, H., Schauer, S. L., Sherr, D. H., and Sonenshein, G. E. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol., 16: 5015-5025, 1996.
47. Lee, H., Arsura, M., Wu, M., Duyao, M., Buckler, A. J., and Sonenshein, G. E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med., 181: 1169-1177, 1995.
48. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H., and Sonenshein, G. E. Inhibition of NF-kB/Rel induces apoptosis of murine B cells. EMBO J., 15: 4682-4690, 1996.
49. McCormack, J. E., Pepe, V. H., Kent, R. B., Dean, M., Marshak-Rothstein, A., and Sonenshein, G. E. Specific regulation of c-myc oncogene expression in a murine B cell lymphoma. Proc. Natl. Acad. Sci. USA, 81: 5546-5550, 1984.
50. Tisch, R., Roifman, C. M., and Hozumi, N. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc. Natl. Acad. Sci. USA, 85: 6914-6918, 1988.
51. Ales-Martinez, J. E., Warner, G. L., and Scott, D. W. Immunoglobulins D and M mediate signals that are qualitatively different in B cells with immature phenotype. Proc. Natl. Acad. Sci. USA, 85: 6919-6923, 1988.
52. Scott, D. W., Livnat, D., Whitin, J., Dillon, S. B., Snyderman, R., and Pennell, C. A. Lymphoma models for B cell activation and tolerance V. Anti-lg mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. J. Mol. Cell. Immunol., 3: 109-120, 1987.
53. Gold, M. R., and DeFranco, A. L. Phorbol esters and dioctanoylglycerol block anti-lgM-stimulated phosphoinositide hydrolysis in the murine B cell lymphoma WEHI-231. J. Immunol., 138: 868-876, 1987.
54. Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40. Eur. J. Immunol., 26: 2425-2432, 1996.
55. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Washington DC), 281: 1312-1316, 1998.
56. Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., and Ross, R. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2:role of caspase cascade. Mol. Cell, 4: 553-563, 1998.
57. Andjelic, S., and Liou, H-C. Antigen receptor-induced B lymphocyte apoptosis mediated via a protease of the caspase family. Eur. J. Immunol., 28: 570-581, 1998.
58. Ueda, H., Manda, T., Matsumoto, S., Mukumoto, S., Nishigaki, F., Kawamura, I., and Shimomura, K. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. III. Antitumor activities on experimental tumor in mice. J. Antibiot. (Tokyo), 47: 315-323, 1994.
59. Ueda, H., Nakajima, H., Hori, Y., Goto, T., and Okuhara, M. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci. Biotech. Biochem., 58: 1579-1583, 1994.
60. Wang, R., Brunner, T., Zhang, L., and Shi, Y. Role of c-Myc in Fas ligand expression: fungal metabolite FR901228 inhibits c-Myc expression and activation-induced apoptosis. Oncogene, 17:1503-1508, 1998.
61. Rothstein, T. L., Baeker, T. R., Miller, R. A., and Kolber, D. L. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell. Immunol., 102: 364-373, 1986.
62. Sigal, N. H., and Dumont, F. J. Cyclosporin A, FK-506, and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol., 10: 519-560, 1992.
63. Berridge, M. J. Lymphocyte activation in health and disease. Crit. Rev. Immunol., 17: 155-178, 1997.
64. Tsubata, T., Wu, J., and Honjo, T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature (Lond.), 364: 645-648, 1993.
65. Wang, Z., Karras, J. G., Howard, R. G., and Rothstein, T. L. Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J. Immunol., 155: 3722-3725, 1995.
66. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol., 25: 1352-1357, 1995.
67. L, Cdk4, and Cdk6. J. Immunol., 155: 5527-5535, 1995.
68. Schauer, S. L., Wang, Z., Sonenshein, G. E., and Rothstein, T. L. Maintenance of nuclear factor-kB/Rel and c-myc expression during CD40L rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of lκB proteins. J. Immunol., 157: 81-86, 1996.
69. Schauer, S. L., Bellas, R. E., and Sonenshein, G. E. Dominant signals leading to inhibitor κB protein egradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J. Immunol., 160: 4398-4405, 1998.
70. Krieg, A. M., Yi, A-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond.), 374: 546-549, 1995.
71. L. J. Immunol., 157: 4918-4925, 1996.
72. Hagiyama, H., Adachi, T., Yoshida, T., Nomura, T., Miyasaka, N., Honjo, T., and Tsubata, T. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis. Oncogene, 18: 4091-4098, 1999.
73. Thompson, E. B. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol., 60: 575-600, 1998.
74. Fanidi, A., Harrington, E. A., and Evan, G. E. Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature (Lond.), 359: 554-556, 1992.
75. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R. Apoptotic cell death by c-myc is inhibited by bcl-2. Nature (Lond.), 359: 552-554, 1992.
76. Wu, M., Yang, W., Bellas, R. E., Schauer, S. L., FitzGerald, M. J., Lee, H., and Sonenshein, G. E. c-Myc promotes survival of WEHI 231 B lymphoma cells from apoptosis. Curr. Top. Microbiol. Immunol., 224: 91-101, 1997.
77. Arsura, M., Deshpande, A., Hann, S. R., and Sonenshein, G. E. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transaction. Mol. Cell. Biol., 15: 6702-6709, 1995.
78. Muthukkumar, S., Udhayakumar, V., and Bondada, S. Elevation of cytosolic free calcium is sufficient to induce growth inhibition in a B cell lymphoma. Eur. J. Immunol., 23: 2419-2426, 1993.
79. Bonnefoy-Berard, N., Genestier, L., Flacher, M., and Revillard, J. P. The phosphoprotein phosphatase calcineurin controls calcium-dependent apoptosis in B cell lines. Eur. J. Immunol., 24: 325-329, 1994.
80. Furuya, Y., Ohta, S., Yasuda, K., and Ito, H. Enhanced expression of cyclin-dependent kinase inhibitor in apoptosis of androgen-independent prostatic cancer cell line induced by calcium ionophore. Anticancer Res., 17: 2391-2394, 1997.
81. Kip1 deficient mice. Cell, 85: 733-744, 1996.
82. Nakayama, K., lshida, N., Shirane, M., lnomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y. and Nakayama, K. Mice lacking p27KEp1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
83. Kip1 is haplo-insufficient for tumor suppression. Nature (Lond.), 396: 177-180, 1998.
84. kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol., 154: 313-323, 1999.